Health
Abbott's Dissolving Stent Receives Health Canada Approval for Treating Blocked Arteries Below-the-Knee
Abbott (NYSE: ABT) today announced that Health Canada has authorized the Esprit™ BTK Everolimus Eluting Resorbable Scaffold System (Esprit BTK System), a first-of-its kind treatment innovation for people with chronic limb threatening ischemia (CLTI) below-the-knee (BTK). The Esprit BTK System is designed to keep arteries open and deliver a drug, everolimus, to support vessel healing prior to completely dissolving.
About this update from Abbott Laboratories
[{"type":"list","items":[{"val":[{"type":"text","content":"More than 800,000 Canadians1 live with peripheral artery disease (PAD) with limited treatment options to date1","length":110,"tagName":"p"}]},{"val":[{"type":"text","content":"The first-of-its-kind dissolvable stent, the Esprit™ BTK Everolimus Eluting Resorbable Scaffold, dissolves over time after it has opened blocked arteries below-the-knee (BTK)","length":179,"tagName":"p"}]},{"val":[{"type":"text","content":"The dissolving stent offers the possibility of better outcomes for people with the most severe form of PAD","length":111,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":400,"olType":false},{"type":"text","content":"TORONTO, Sept. 29, 2025 /CNW/ -- Abbott (NYSE: ABT) today announced that Health Canada has authorized the Esprit™ BTK Everolimus Eluting Resorbable Scaffold System (Esprit BTK System), a first-of-its kind treatment innovation for people with chronic limb threatening ischemia (CLTI) below-the-knee (BTK). The Esprit BTK System is designed to keep arteries open and deliver a drug, everolimus, to support vessel healing prior to completely dissolving.","length":455,"tagName":"p"},{"type":"text","content":"Until this recent Health Canada approval for the Esprit BTK System, the standard of care has been balloon angioplasty, which relies on a small balloon delivered via a catheter to the blockage to compress it against the arterial wall, opening the vessel and restoring blood flow. However, blockages treated only with balloon angioplasty can have poor short-and long-term results, and in many instances, the vessels become blocked again, requiring additional treatment.","length":467,"tagName":"p"},{"type":"text","content":"The Esprit BTK System is a first-of-its-kind dissolvable stent and is comprised of material similar to dissolving sutures. The device is implanted during a catheter-based minimally invasive procedure via a small incision in the leg. Once the blockage is open, the Esprit BTK System helps heal the vessel and provides support for approximately three years until the vessel is strong enough to remain open on its own.","length":415,"tagName":"p"},{"type":"text","content":"In November 2024 at the Vascular InterVentional Advances (VIVA) Conference in Las Vegas, Abbott released late-breaking clinical data on the LIFE-BTK trial two-year results.4 The ...